Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model

Area of Science:

• Pharmacology
• Respiratory Medicine
• Immunology

Background:

• Adenosine is increasingly recognized as a mediator in allergic asthma.
• Asthma research benefits from animal models that mimic human physiology and drug responses.

Purpose of the Study:

• To identify the specific adenosine receptor subtype involved in asthmatic airway responses.
• To characterize adenosine's role in a validated allergic rabbit model of late-phase asthma.

Main Methods:

• Utilized an allergic rabbit model exhibiting late-phase asthma characteristics.
• Administered adenosine and selective adenosine receptor agonists (NECA, CGS-21680, CPA) to assess bronchoconstriction.
• Measured agonist potency using PC50 values to determine receptor subtype involvement.
• Investigated adenosine's effect on bronchial hyperresponsiveness (BHR).

Main Results:

• Adenosine induced dose-dependent bronchoconstriction in allergic rabbits, but not in normal rabbits.
• Theophylline, an adenosine receptor antagonist, significantly inhibited adenosine-induced bronchoconstriction.
• The potency order of agonists (CPA > NECA > CGS-21680 > adenosine) indicated a primary role for the A1-receptor subtype.
• Adenosine exposure led to increased bronchial hyperresponsiveness at 1 hour post-challenge.

Conclusions:

• The A1-adenosine receptor subtype mediates adenosine-induced bronchoconstriction in this allergic asthma model.
• Adenosine contributes to airway hyperresponsiveness in allergic asthma.
• Findings suggest the A1-adenosine receptor as a potential therapeutic target for allergic asthma.